Adenoviral infections in hematopoietic stem cell transplantation.

[1]  P. Veys,et al.  Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation , 2005, British journal of haematology.

[2]  E. Claas,et al.  Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery , 2005, Bone Marrow Transplantation.

[3]  J. Atkinson,et al.  Localization of Regions in CD46 That Interact with Adenovirus , 2005, Journal of Virology.

[4]  V. Saha,et al.  Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary? , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  M. Schilham,et al.  Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. , 2005, The Journal of infectious diseases.

[6]  R. Handgretinger,et al.  Detection of adenovirus‐specific T cells in children with adenovirus infection after allogeneic stem cell transplantation , 2005, British journal of haematology.

[7]  S. Dupuis-Girod,et al.  In Vitro Susceptibility of Adenovirus to Antiviral Drugs is Species-Dependent , 2005, Antiviral therapy.

[8]  C. Rooney,et al.  Adenovirus as an emerging pathogen in immunocompromised patients , 2005, British journal of haematology.

[9]  R. Medzhitov,et al.  Toll-like receptors: linking innate and adaptive immunity. , 2004, Microbes and infection.

[10]  D. Muruve,et al.  The innate immune response to adenovirus vectors. , 2004, Human gene therapy.

[11]  C. Rooney,et al.  Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells. , 2004, Blood.

[12]  L. Eisenlohr,et al.  Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele , 2004, Gene Therapy.

[13]  M. Schilham,et al.  Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  R. Krance,et al.  Prompt versus preemptive intervention for EBV lymphoproliferative disease. , 2004, Blood.

[15]  C. Fegan,et al.  Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[16]  H. Heslop,et al.  Adoptive immunotherapy for posttransplantation viral infections. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  H. Einsele,et al.  Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy. , 2004, Experimental hematology.

[18]  C. Rooney,et al.  Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications. , 2004, Blood.

[19]  C. Rouzioux,et al.  Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  A. Gaggar,et al.  CD46 is a cellular receptor for group B adenoviruses , 2003, Nature Medicine.

[21]  R. M. Burnett,et al.  Structural and Phylogenetic Analysis of Adenovirus Hexons by Use of High-Resolution X-Ray Crystallographic, Molecular Modeling, and Sequence-Based Methods , 2003, Journal of Virology.

[22]  F. Watzinger,et al.  Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. , 2003, Blood.

[23]  A. Heim,et al.  Rapid and quantitative detection of human adenovirus DNA by real‐time PCR , 2003, Journal of medical virology.

[24]  M. Schilham,et al.  Extensive Cross-Reactivity of CD4+ Adenovirus-Specific T Cells: Implications for Immunotherapy and Gene Therapy , 2003, Journal of Virology.

[25]  M. Horwitz,et al.  The impact of adenovirus infection on the immunocompromised host , 2003, Reviews in medical virology.

[26]  A. Gaggar,et al.  The Interaction between the Fiber Knob Domain and the Cellular Attachment Receptor Determines the Intracellular Trafficking Route of Adenoviruses , 2003, Journal of Virology.

[27]  H. Einsele,et al.  Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation , 2003, Bone Marrow Transplantation.

[28]  S. Akira,et al.  Toll-like receptors. , 2003, Annual review of immunology.

[29]  C. Fegan,et al.  Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. , 2002, Blood.

[30]  L. Eisenlohr,et al.  The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope. , 2002, Human gene therapy.

[31]  P. Gavin,et al.  Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. , 2002, Pediatrics.

[32]  Hans-Georg Rammensee,et al.  Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. , 2002, Blood.

[33]  A. Fischer,et al.  Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy. , 2002, Human Gene Therapy.

[34]  P. Boulanger,et al.  Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response , 2002, Journal of Virology.

[35]  N. Kapoor,et al.  Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[36]  E. Holler,et al.  Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study , 2001, Bone Marrow Transplantation.

[37]  A. Davis,et al.  Efficient infection of primitive hematopoietic stem cells by modified adenovirus , 2001, Gene Therapy.

[38]  A. L. Le Faou,et al.  Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  L. Elting,et al.  Adenovirus infections in adult recipients of blood and marrow transplants. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  M. Peuchmaur,et al.  Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children , 2001, Bone Marrow Transplantation.

[41]  R. Crystal,et al.  Adenovirus Serotype 7 Retention in a Late Endosomal Compartment prior to Cytosol Escape Is Modulated by Fiber Protein , 2001, Journal of Virology.

[42]  F. Chisari,et al.  Noncytolytic control of viral infections by the innate and adaptive immune response. , 2001, Annual review of immunology.

[43]  L. Eisenlohr,et al.  Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults. , 2001, Viral immunology.

[44]  D. Schendel,et al.  Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant , 2001, Bone Marrow Transplantation.

[45]  N. Goulden,et al.  Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation , 2000, Bone Marrow Transplantation.

[46]  A. Lieber,et al.  Dependence of Adenovirus Infectivity on Length of the Fiber Shaft Domain , 2000, Journal of Virology.

[47]  A. Kidd,et al.  Adenovirus Type 37 Uses Sialic Acid as a Cellular Receptor , 2000, Journal of Virology.

[48]  R. M. Burnett,et al.  Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[49]  G. Kreitzer,et al.  Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. , 2000, Human gene therapy.

[50]  M Pittard,et al.  Adenovirus infections in hematopoietic stem cell transplant recipients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  T. Schumacher,et al.  Selective Expansion of Cross-Reactive Cd8+ Memory T Cells by Viral Variants , 1999, The Journal of experimental medicine.

[52]  W. Wold,et al.  Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. , 1999, Current opinion in immunology.

[53]  R. Crystal,et al.  Fiber Swap between Adenovirus Subgroups B and C Alters Intracellular Trafficking of Adenovirus Gene Transfer Vectors , 1999, Journal of Virology.

[54]  A. Wald,et al.  Development of a High-Throughput Quantitative Assay for Detecting Herpes Simplex Virus DNA in Clinical Samples , 1999, Journal of Clinical Microbiology.

[55]  Urs F. Greber,et al.  Microtubule-dependent Plus- and Minus End–directed Motilities Are Competing Processes for Nuclear Targeting of Adenovirus , 1999, The Journal of cell biology.

[56]  D. Busch,et al.  T Cell Affinity Maturation by Selective Expansion during Infection , 1999, The Journal of experimental medicine.

[57]  H. Heslop,et al.  Adenovirus infection after pediatric bone marrow transplantation , 1999, Bone Marrow Transplantation.

[58]  B. Mercier,et al.  Simultaneous screening for HBV DNA and HCV RNA genomes in blood donations using a novel TaqMan PCR assay. , 1999, Journal of virological methods.

[59]  J. Ticehurst,et al.  PCR Method for Detection of Adenovirus in Urine of Healthy and Human Immunodeficiency Virus-Infected Individuals , 1998, Journal of Clinical Microbiology.

[60]  C. Rooney,et al.  Extensive cross-reactivity of adenovirus-specific cytotoxic T cells. , 1998, Human gene therapy.

[61]  B. Ramsey,et al.  Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. , 1998, Pediatrics.

[62]  D. Srivastava,et al.  Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. , 1998, Blood.

[63]  A. Helenius,et al.  The role of the nuclear pore complex in adenovirus DNA entry , 1997, The EMBO journal.

[64]  P. Pring-Åkerblom,et al.  PCR-based detection and typing of human adenoviruses in clinical samples. , 1997, Research in virology.

[65]  B. Robertson,et al.  Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system , 1996, Journal of clinical microbiology.

[66]  C. Rooney,et al.  Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro , 1996, Journal of virology.

[67]  R. Truitt,et al.  Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon , 1996, Journal of virology.

[68]  G. Boiteau,et al.  J. Virol. Methods , 1996, Journal of Virological Methods.

[69]  Malcolm K. Brenner,et al.  Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes , 1996, Nature Medicine.

[70]  A. Helenius,et al.  The role of the adenovirus protease on virus entry into cells. , 1996, The EMBO journal.

[71]  D. Schnurr,et al.  Analysis of 15 adenovirus hexon proteins reveals the location and structure of seven hypervariable regions containing serotype-specific residues , 1996, Journal of virology.

[72]  S. Riddell,et al.  Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.

[73]  R. Truitt,et al.  Characterization of human proliferative T cell responses to adenovirus. , 1995, The Journal of infectious diseases.

[74]  R. Krance,et al.  Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation , 1995, The Lancet.

[75]  K. Cornetta,et al.  Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. , 1994, Blood.

[76]  M. Horowitz,et al.  Increasing incidence of adenovirus disease in bone marrow transplant recipients. , 1994, The Journal of infectious diseases.

[77]  S. Riddell,et al.  Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones. , 1994, Bone marrow transplantation.

[78]  P. Pring-Åkerblom,et al.  Type- and group-specific polymerase chain reaction for adenovirus detection. , 1994, Research in virology.

[79]  J. Wilson,et al.  Gene therapy: adenovirus vectors. , 1993, Current opinion in genetics & development.

[80]  W. Wold,et al.  Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. , 1991, Virology.

[81]  R. Girones,et al.  Polymerase chain reaction for detection of adenoviruses in stool samples , 1990, Journal of clinical microbiology.

[82]  W. Wold,et al.  Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor. , 1989, Molecular biology & medicine.